GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » Cash Flow from Financing

Asiatic Laboratories (DHA:ASIATICLAB) Cash Flow from Financing : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in . 20, Asiatic Laboratories paid BDT0.00 Mil more to buy back shares than it received from issuing new shares. It received BDT0.00 Mil from issuing more debt. It paid BDT0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received BDT0.00 Mil from paying cash dividends to shareholders. It received BDT0.00 Mil on other financial activities. In all, Asiatic Laboratories spent BDT0.00 Mil on financial activities for the six months ended in . 20.


Asiatic Laboratories Cash Flow from Financing Historical Data

The historical data trend for Asiatic Laboratories's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories Cash Flow from Financing Chart

Asiatic Laboratories Annual Data
Trend
Cash Flow from Financing

Asiatic Laboratories Semi-Annual Data
Cash Flow from Financing

Asiatic Laboratories Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Asiatic Laboratories's Cash from Financing for the fiscal year that ended in . 20 is calculated as:

Asiatic Laboratories's Cash from Financing for the quarter that ended in . 20 is:


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Financing for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asiatic Laboratories  (DHA:ASIATICLAB) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Asiatic Laboratories's issuance of stock for the six months ended in . 20 was BDT0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Asiatic Laboratories's repurchase of stock for the six months ended in . 20 was BDT0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Asiatic Laboratories's net issuance of debt for the six months ended in . 20 was BDT0.00 Mil. Asiatic Laboratories received BDT0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Asiatic Laboratories's net issuance of preferred for the six months ended in . 20 was BDT0.00 Mil. Asiatic Laboratories paid BDT0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Asiatic Laboratories's cash flow for dividends for the six months ended in . 20 was BDT0.00 Mil. Asiatic Laboratories received BDT0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Asiatic Laboratories's other financing for the six months ended in . 20 was BDT0.00 Mil. Asiatic Laboratories received BDT0.00 Mil on other financial activities.


Asiatic Laboratories Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines